FDA LISTING INC: EXPERIENCED ADVISORS FOR FULL-SERVICE FDA REGISTRATION & COMPLIANCE
+1 212 444 8202
Click the button below to see the service steps in an easy-to-follow graphic format.
A 510(k) premarket notification may be required before a medical device can be commercially distributed in the United States. The applicable pathway depends on the device’s classification, FDA product code, intended use, technological characteristics, and any applicable exemption. Certain Class I and Class II devices are exempt from 510(k) requirements. Other devices require 510(k) clearance before commercial distribution. Devices subject to Premarket Approval (PMA) follow a separate premarket pathway.
The 510(k) requirement must be evaluated based on the specific device. The device name or the existence of similar products on the market does not, by itself, establish the applicable regulatory pathway.
Changes to a previously cleared device—including changes to design, materials, manufacturing processes, software, labeling, intended use, or indications for use—may also require a new 510(k) or a documented regulatory assessment. FDA establishment registration and device listing are separate requirements and do not substitute for 510(k) clearance when premarket notification is required.
A 510(k) is a premarket notification submitted to the FDA to demonstrate that a device is substantially equivalent to a legally marketed predicate device.
The substantial-equivalence assessment generally addresses whether the subject device has the same intended use as the predicate and whether differences in technological characteristics raise different safety and effectiveness questions. Supporting information may include performance testing, labeling, risk information, and other technical documentation, as applicable.
A 510(k) results in FDA clearance, not FDA approval. Devices subject to Premarket Approval follow a separate FDA approval pathway. Predicate selection is a key component of the 510(k) strategy. The predicate should be legally marketed and appropriate for the intended use and technological characteristics of the subject device. An unsuitable predicate or inadequately supported technological differences may result in FDA questions, additional-information requests, or reconsideration of the proposed regulatory pathway.
The content of a 510(k) depends on the device type, classification, product code, intended use, technological characteristics, claims, predicate device, and applicable FDA requirements.
A 510(k) submission commonly includes:
Most 510(k) submissions—including Traditional, Special, and Abbreviated 510(k)s—are prepared and submitted electronically using FDA’s electronic Submission Template and Resource (eSTAR), unless an applicable exemption or waiver applies. eSTAR is submitted through the CDRH Portal and incorporates structured content and validation features to support submission preparation. FDA subsequently conducts its applicable acceptance and substantive reviews and may request additional information.
Preparation timelines depend on device complexity, predicate availability, technical file completeness, testing requirements, and the quality of existing documentation. You must generally pay the applicable FDA user fee before the FDA accepts the 510(k) for review, unless an exemption applies.
510(k) clearance is not FDA approval. The FDA has determined a cleared device to be substantially equivalent to a legally marketed predicate. A manufacturer should not represent a 510(k)-cleared device as “FDA approved” solely because of 510(k) clearance.
Registration and listing are separate requirements. Following 510(k) clearance, the manufacturer must complete applicable FDA establishment registration and device listing requirements. The device listing should accurately reflect the cleared device and applicable premarket submission information.
Changes to a cleared device require regulatory assessment. Changes to device design, materials, manufacturing processes, software, labeling, intended use, indications for use, or other technological characteristics should be evaluated to determine whether a new 510(k) is required.
FDA user fees apply. FDA charges user fees for most 510(k) submissions. Manufacturers seeking the reduced small-business user fee should obtain an FDA Small Business Determination before paying the user fee and submitting the 510(k). Eligibility is based on FDA’s applicable small-business criteria.
After FDA clearance, the manufacturer receives a 510(k) number (K number) for the cleared device. The device may then be commercially distributed in the United States, provided the manufacturer has satisfied all other applicable FDA requirements. Post-clearance requirements may include:
Foreign establishments that manufacture, prepare, propagate, compound, assemble, or process medical devices for U.S. distribution generally must comply with applicable FDA establishment registration, device listing, and U.S. Agent requirements.
FDA Listing Inc. provides practical 510(k) consulting and submission support for medical device manufacturers seeking U.S. market access. We tailor our support to the device, intended use, available technical documentation, potential predicate devices, and applicable testing requirements.
We can assist with:
The scope, fees, and timelines for 510(k) consulting and submission support depend on the device classification, predicate strategy, technical documentation, testing requirements, and overall submission complexity.
Service Details & Fees
Drug Establishment Registration
OTC Drug Listing
Time Required
U.S. Agent
Obtaining NDC codes
OTC Label Assessment
FDA Registration Certificate
495 USD
495 USD
4-5 Days
_______ Related Services _______
Frequently Asked Questions (FAQ)
No. The applicable premarket pathway depends on the device classification, product code, intended use, and any applicable FDA exemption. Depending on the device, the applicable pathway may include 510(k), De Novo, PMA, or an exemption from premarket notification.
No. A 510(k) is a premarket notification pathway based on substantial equivalence to a legally marketed predicate device. Devices subject to Premarket Approval follow a separate FDA approval pathway.
FDA’s MDUFA performance goal is to issue a decision on 95% of 510(k) submissions within 90 FDA days. This is an FDA performance goal, not a guaranteed total calendar timeline. Actual timelines may vary based on submission completeness, device complexity, FDA review, and requests for additional information.
A predicate device is a legally marketed device used as the comparison device in a 510(k) submission. The subject device generally must have the same intended use as the predicate, and its technological differences must not raise different questions of safety and effectiveness.
No. Establishment registration and device listing are separate FDA requirements. When a device requires 510(k) clearance, you must satisfy the applicable premarket requirements before commercial distribution.
The electronic Submission Template and Resource (eSTAR) is FDA’s electronic submission template used for 510(k) and certain other medical device premarket submissions. Unless an applicable exemption or waiver applies, 510(k) submissions are prepared using eSTAR and submitted through the CDRH Portal.
Yes. Certain changes to device design, materials, manufacturing processes, software, labeling, intended use, or indications for use may require a new 510(k). Manufacturers should conduct an appropriate regulatory assessment before implementing significant changes to a cleared device.
_______ Related Services _______